Form 8-K CYTOKINETICS INC For: Sep 15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cytokinetics meets with FDA on aficamten drug application
September 16, 2025 4:12 PM EDTCytokinetics (NASDAQ: CYTK) participated in a late cycle meeting with the Food and Drug Administration on September 15, 2025, regarding its new drug application for aficamten in obstructive hypertrophic cardiomyopathy.
The company discussed its proposed risk evaluation and mitigation strategy program and anticipated post-marketing... More
